@dremmacbw

Clinician Scientist #infectiousdisease #COVID19 @TheCrick @UCLHResearch @uclh @HTropDis @UCLInfectImm Passionate about health & vaccine equity

 London
crick.ac.uk/research/research-partnerships/strategic-partnerships/legacy-study
Joined October 2015
  • Tweets2.4K
  • Following1.1K
  • Followers1.7K
57Media
🚨Out today @TheLancet from @TheCrick @UCLHResearch Legacy study thelancet.com/journals/lance… Two different COVID-19 mRNA vaccines were deployed for 5th dose boosters in the UK #JCVI We tested if either 💉 generated neutralizing antibodies against BA.2.86 & JN.1 A short🧵 👇
5
25
6
70
32,424
Calling early-career medical researchers worldwide!  Progress your career via a new Nuffield Medical Fellowship at @UniofOxford The Fellowship offers a job contract, 5 years of research funding, and career progression opportunities. Apply now: medsci.ox.ac.uk/nuffield-med…
Three images of medical researchers, University of Oxford logo, and the text: Nuffield Medical Fellowships - Fellowships for outstanding early-career medical researchers. Applications are encouraged from candidates worldwide. Visit our website to learn more.

ALT Three images of medical researchers, University of Oxford logo, and the text: Nuffield Medical Fellowships - Fellowships for outstanding early-career medical researchers. Applications are encouraged from candidates worldwide. Visit our website to learn more.

1
39
87
7,155
Exciting opportunity at Yale 📢 We are seeking a Medical Director for the Yale New Haven Hospital Multi-Specialty Long COVID Care Center. Pls spread the word! Interested candidates should contact @LisaSandersMD. #LongCOVID #Medicine #InternalMedicine #PostAcuteInfectionSyndrome
9
112
10
269
23,209
🧵🧵🧵The full RECOVER-VITAL paper is out, with expected results, some surprises, and questions that still need to be answered. Nirmatrelvir–ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Infectious Diseases thelancet.com/journals/lanin…

Nirmatrelvir–ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the...

Nirmatrelvir–ritonavir for 15 days or 25 days showed no evidence of benefit in long COVID in any of the three phenotypes studied. These findings suggest additional approaches to measuring the symptom...

thelancet.com
4
30
3
96
5,452
🚨#LongCOVID co-patient led clinical trial STIMULATE-ICP @TheLancetInfDis today thelancet.com/journals/lanin… Fatigue improved >10% in all arms Additional small improvement in colchicine & famotidine/loratadine but *not* rivaroxaban arms @NIHRresearch @uclh @ucl @amibanerjee1

Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist support...

In participants with long COVID, severe fatigue reduced in all study groups—including the no drug group—over 12 weeks, with small additional reductions in the colchicine and famotidine–loratadine...

thelancet.com
2
5
2
10
1,681
Have you been invited? Have you received an invitation to the PHOSP-COVID 5-year follow-up study? 🖥️ A short online survey + 🧠 optional cognitive tests – your experience still matters.
1
8
14
901
Paper published today in @BMJ_Open from our group describing trajectory of 3590 patients with #longcovid Important insights into inpatient and outpatient treated cohorts, impact of vaccine before illness, recovery trajectories and health economics bmjopen.bmj.com/content/16/1…

Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year...

Objective To characterise long-term trajectory of recovery in individuals with long covid. Design Prospective cohort. Setting Single-centre, specialist post-COVID service (London, UK). Participants...

bmjopen.bmj.com
1
5
8
357
Clinical trajectories of > 3500 patients with #LongCovid @uclh 2020-2024. 🚨 Only 1/3 recovered🚨 ➡️ Vaccination predicts recovery ➡️ Severe fatigue, POTS and PEM predicts slower recovery/non-recovery ➡️ LC clinic *reduces* GP and ED visits 👇 bmjopen.bmj.com/content/16/1…

Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year...

Objective To characterise long-term trajectory of recovery in individuals with long covid. Design Prospective cohort. Setting Single-centre, specialist post-COVID service (London, UK). Participants...

bmjopen.bmj.com
1
87
Lecturer in Immunology of Host-pathogen Dynamics at Queen Mary University of London. Great opportunity to work with Emma Wall, setting up a new lab at QMUL. jobs.ac.uk/job/DPT444/lectur…
1
5
12
849
💡I'm hiring 💡 Lecturer in Immunology of host-pathogen dynamics @QMUL Blizard Link here ⬇️⬇️ jobs.ac.uk/job/DPT444/lectur… Deadline 29th January
1
127
Great to see this published. A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID doi.org/10.1038/s41467-025-6…
3
7
827
📢 Final weeks to join the PHOSP-COVID study! For more info: phosp-i.org/phosp-i @LeicResearch @UoLRespSci @kingshealth @CRFsheffield @Shef_Research @BirminghamCRF @uhbtrust @GlasgowCRF @ManchesterCRF @ncaresearchnhs @NorthBristolNHS @CV_UHB @nhsuhcw @REvans_Breathe
PHOSP-COVID study@PHOSP_COVID10 Jul 2025
We're still recruiting! Do you have Long Covid & 18-80 years? The University of Leicester are running a trial to see if an anti-inflammatory drug helps people with LC feel better. If you are interested in taking part, please contact [email protected] @long_covid #LongCovid
3
1
6
1,162
Promoter variation in Streptococcus: S. pneumoniae promoters contain repetitive nucleotides, driving strand slippage & promoter mutations. This drives population-level heterogeneity in gene expression, offering evolutionary strategy to maximize fitness cell.com/cell-host-microbe/f…

Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes

Barton et al. identify Streptococcus pneumoniae promoters containing repetitive nucleotide sequences that promote DNA strand slippage and accumulation of promoter sequence mutations. This drives...

cell.com
7
18
1,596
"We often talk about the importance of research but rarely about the researchers. We celebrate innovation but overlook the innovators... blueprints do not build anything without skilled hands"
The BMJ
@bmj_latest1 Sep 2025
"We celebrate innovation but overlook the innovators." The UK is rapidly losing medical academics and without them has no hope of achieving its plans to become a leader in research, say @DocStrain @gibb_jonathan @BMA_Academics bmj.com/content/390/bmj.r180…

The UK is rapidly losing medical academics and without them the NHS 10 year plan is at risk

The upcoming NHS workforce plan is an opportunity to turn this shortage around, write David Strain and Jonathan Gibb In July 2025, the UK government launched two ambitious strategies with a shared...

bmj.com
1
4
15
2,075
A great Keystone meeting on Long COVID this week in Santa Fe. The field has made great progress recently, but there is much more to do. Exciting science presented about viral and immune mechanisms, clinical data and future clinical trials. keystonesymposia.org/confere…

Long COVID and Other Post-Acute Infection Syndromes | Keystone Symposia

Join us at the Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes, August 2025, in Santa Fe, with field leaders!

keystonesymposia.org
6
23
2,006
We're hiring a sequencing technician for #TRACERx! Interested in cutting-edge genomic tech to understand cancer? 👉 tinyurl.com/myh4un9j #Genomics #CancerResearch Join our world-leading teams at @TheCrick & @uclcancer

UCL – University College London

UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

ucl.ac.uk
1
15
34
3,758
Emma Wall retweeted
UCLH@uclh6 Jun 2025
It has been five years since the post-Covid clinic was set up outside University College Hospital. The team has since expanded and continues to provide vital support as new cases emerge and some patients experience long-term effects. buff.ly/iCJkwnM
2
4
13
1,552
Emerging Clinical Researchers Awards 2025 - Open to Applications. Deadline 31 May 2025 🧑‍💻 To find out more, follow the link below⬇️ linkedin.com/pulse/emerging-… #ECR #TranslationalMedicine
3
1
1
948
This will be a great ECR infection symposium in June! It's not too late to submit abstracts, we've just extended the deadline! ⏬️
London Infection Network for/by ECRs (LINE)@LondonECR28 Apr 2025
We can see our LINE symposium already on the horizon (9th of June) @TheCrick. shorturl.at/MyWNl 🥳 You can now submit your abstracts (talk or poster) until the EXTENDED DEADLINE on the 12th of May here: shorturl.at/7KuXL Free registration shorturl.at/wLyWY
1
2
237
🚨We're hiring 🚨 FY2 + NHS exp Clinical Research Fellow - SARS-CoV-2 Legacy study @UCLHresearch @TheCrick crick.ac.uk/legacy-study Deadline 6th May 2025 👇 apps.trac.jobs/job-advert/71… Please RT
4
1
1,092
Emma Wall retweeted
Emma Thomson@emcat126 Mar 2025
New in Nature Comms: We applied metagenomic and targeted NGS to serum samples from undiagnosed febrile patients across Uganda. This work highlights how NGS can transform viral surveillance in LMICs—especially with infrastructure now in place post-COVID. 🔗 nature.com/articles/s41467-0…

Uncovering the viral aetiology of undiagnosed acute febrile illness in Uganda using metagenomic...

Nature Communications - Acute febrile illness is common in sub-Saharan Africa and causative agents are often unknown. Here, the authors perform metagenomic sequencing on samples from patients with...

nature.com
4
36
2
105
11,117
Load more